<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the effect of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> on <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>-like pathological and <z:hpo ids='HP_0000708'>behavioral changes</z:hpo> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Rats were treated for 2 months with high fat diet (HFD) followed by <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> (STZ) injection to induce type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (HFD-STZ model) </plain></SENT>
<SENT sid="2" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) was used to induce cerebral focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Animals were divided into four groups: Sham-NPD, Sham-HFD-STZ, MCAO-NPD and MCAO-HFD-STZ </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed that HFD-STZ treatment induced <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, characteristics of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The performance of rats in the <z:mp ids='MP_0001465'>Morris water maze</z:mp> test was impaired in MCAO-NPD and Sham-HFD-STZ rats, indicating <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Hippocampal caspase-3+ and beta amyloid (Abeta+) cell numbers, as well as beta-site amyloid precursor protein-cleaving enzyme (BACE1) levels and activity, increased in both groups </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, HFD-STZ treatment exacerbated <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo>, additively increased MCAO-induced activation of caspase-3, and increased levels of BACE1, C99 and Abeta </plain></SENT>
<SENT sid="8" pm="."><plain>However, the level of insulin decreased in MCAO-HFD-STZ rats </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggested that type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> deteriorated <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced brain damage and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, which might be associated with increased Abeta generation and cytotoxicity </plain></SENT>
<SENT sid="10" pm="."><plain>We concluded that type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> exacerbated poststroke <z:hpo ids='HP_0000726'>dementia</z:hpo> possibly due to brain injury and synergistic generation of Abeta via activation of BACE1 </plain></SENT>
</text></document>